Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis

Completed · Phase 3

Conditions studied: Endogenous Anterior Uveitis

In brief

The purpose of this study was to demonstrate that difluprednate 0.05% (Durezol) dosed 4 times daily is noninferior to prednisolone 1% (Pred Forte) dosed 8 times daily for the treatment of endogenous anterior uveitis.

Key facts

Study ID
NCT01201798
Run by
Alcon Research
People needed
111
Starts
2010-10-01
Expected to finish
2011-08-01
Last updated by the study team
2012-11-15

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.